CanFite Wins U.S. Patent For The Reduction Of Intraocular Pressure

– Can-Fite BioPharma Ltd. (TASE: CFBI), (OTCQB: CANFY) and its subsidiary, OphthaliX Inc. (OTCQB: OPLI), jointly announced today that the U.S. Patent and Trademark Office granted a U.S. patent More...